Herlev og Gentofte Hospital, Region H

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials

Phase

• Phase 1/21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Boehringer Ingelheim1 trial
• Gentofte Hospital1 trial

Running trials

• Active, not recruiting

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· Phase 3· Boehringer Ingelheim· Source

• Not yet recruiting

  A 6-Month, Randomized, Double-Blind Study to Evaluate the Effect of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease (DECODE-CKD)

  2024-517040-65-02· Phase 1/2· Gentofte Hospital· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting